STAT+: Pharma critic Bernie Sanders is set to hold major sway over FDA funding bill

WASHINGTON – Democrats’ landslide victory in the midterm elections may have significant implications for the upcoming negotiations over a key funding source for the Food and Drug Administration in part by empowering a major critic of the program…

Read the full story at STAT ↗